Trials / Completed
CompletedNCT03376295
Comparative Effectiveness of COPD Treatments
Comparative Effectiveness of Combination Therapies in COPD
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,954 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness of maintenance treatment of Chronic obstructive pulmonary disease (COPD) with the combination of a long-acting bronchodilators (LABA and the long-acting muscarinic antagonists (LAMA) tiotropium (LABA-TIO)) compared with the combination of a LABA and an ICS (LABA-ICS) on the time to COPD exacerbation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LABA and the LAMA tiotropium (LABA-TIO) | combinational drug |
| DRUG | LABA and an ICS (LABA-ICS) | combinational drug |
Timeline
- Start date
- 2017-12-01
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2017-12-18
- Last updated
- 2019-07-24
- Results posted
- 2019-07-08
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03376295. Inclusion in this directory is not an endorsement.